Issue 31, 2021

Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs

Abstract

Alkaloids, secondary plant metabolites, are used in traditional medicine in many countries to treat various pathological conditions. Securinine, a unique indolizidine alkaloid combining four cycles, “6-azobicyclo[3.2.1]octane” as a key structure fused with α,β-unsaturated-γ-lactone and piperidine ring, has a broad spectrum of actions including anti-inflammatory, antibacterial, neuroprotective and antitumor, and has been previously used in medical practice. It has several reactive centers, which are double bonds at positions 12–13 and 14–15, and this is a challenging scaffold for the synthesis of biologically active compounds. In this review, works on the production of modified securinine derivatives and their biological activity are addressed. Both monovalent and bivalent derivatives that are most promising in our opinion, and have potential for further research, are considered.

Graphical abstract: Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs

Article information

Article type
Review Article
Submitted
31 Mar 2021
Accepted
08 May 2021
First published
26 May 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 19185-19195

Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs

S. Klochkov and M. Neganova, RSC Adv., 2021, 11, 19185 DOI: 10.1039/D1RA02558A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements